Peripheral immune cells may trigger brain damage in Alzheimer's models

Researchers at Washington University School of Medicine reported that targeting peripheral classical dendritic cells (cDC1) in tau-prone mice dramatically lowered brain-resident T cells and protected against neurodegeneration. Although the mice continued to develop tau tangles, they exhibited less neuronal loss and maintained cognitive performance. The team observed few cDC1 cells within the brain, prompting investigation of peripheral tissues such as lymph nodes.

Deleting cDC1 in these sites reduced CD8 T-cell infiltration into the brain, suggesting that tau-induced debris may travel to cervical lymph nodes, activate dendritic cells, and then mobilize T cells that exacerbate damage. While the mechanism remains unproven in humans, the findings hint that therapies modulating peripheral immunity could mitigate Alzheimer-related brain injury without crossing the blood-brain barrier.